Indeed, whilst the exact role of NLRP3 in IBD is not yet fully elucidated, increasing evidence has suggested that appropriate inflammasome activation has a protective effect in colitis and colitis-associated carcinogenesis [41]. This evidence concerns the gene NLRP3 and colitis.